1. Home
  2. SKYQ vs ZVSA Comparison

SKYQ vs ZVSA Comparison

Compare SKYQ & ZVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYQ
  • ZVSA
  • Stock Information
  • Founded
  • SKYQ 2019
  • ZVSA 2014
  • Country
  • SKYQ United States
  • ZVSA United States
  • Employees
  • SKYQ N/A
  • ZVSA N/A
  • Industry
  • SKYQ
  • ZVSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKYQ
  • ZVSA Health Care
  • Exchange
  • SKYQ NYSE
  • ZVSA Nasdaq
  • Market Cap
  • SKYQ 2.0M
  • ZVSA 2.3M
  • IPO Year
  • SKYQ N/A
  • ZVSA N/A
  • Fundamental
  • Price
  • SKYQ $1.90
  • ZVSA $1.08
  • Analyst Decision
  • SKYQ
  • ZVSA Strong Buy
  • Analyst Count
  • SKYQ 0
  • ZVSA 1
  • Target Price
  • SKYQ N/A
  • ZVSA $240.00
  • AVG Volume (30 Days)
  • SKYQ 173.8K
  • ZVSA 3.6M
  • Earning Date
  • SKYQ 11-26-2024
  • ZVSA 11-14-2024
  • Dividend Yield
  • SKYQ N/A
  • ZVSA N/A
  • EPS Growth
  • SKYQ N/A
  • ZVSA N/A
  • EPS
  • SKYQ N/A
  • ZVSA N/A
  • Revenue
  • SKYQ $30,766,012.00
  • ZVSA N/A
  • Revenue This Year
  • SKYQ N/A
  • ZVSA N/A
  • Revenue Next Year
  • SKYQ N/A
  • ZVSA N/A
  • P/E Ratio
  • SKYQ N/A
  • ZVSA N/A
  • Revenue Growth
  • SKYQ N/A
  • ZVSA N/A
  • 52 Week Low
  • SKYQ $1.51
  • ZVSA $1.05
  • 52 Week High
  • SKYQ $5.49
  • ZVSA $42.35
  • Technical
  • Relative Strength Index (RSI)
  • SKYQ N/A
  • ZVSA 27.91
  • Support Level
  • SKYQ N/A
  • ZVSA $1.34
  • Resistance Level
  • SKYQ N/A
  • ZVSA $1.89
  • Average True Range (ATR)
  • SKYQ 0.00
  • ZVSA 0.25
  • MACD
  • SKYQ 0.00
  • ZVSA -0.08
  • Stochastic Oscillator
  • SKYQ 0.00
  • ZVSA 1.29

About SKYQ SKY QUARRY INC

Sky Quarry Inc is a development-stage oil-producing and refining company. The company along with its subsidiaries is engaged in deploying technologies to facilitate the recycling of waste asphalt shingles and remediation of oil-saturated soils. The recycling and production of oil from asphalt shingles is expected to reduce the dependence on landfills for the disposal of waste and to also reduce dependence on foreign and domestic virgin crude oil extraction for industrial uses.

About ZVSA ZyVersa Therapeutics Inc.

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.

Share on Social Networks: